Abstract
Background: Regorafenib is a multikinase inhibitor, indicated for the treatment of metastatic colorectal cancer and locally advanced, unresectable or metastatic gastrointestinal stromal tumor.
Objective: A simple and fast, validated bioanalytical method is required for pre-clinical or clinical safety and efficacy investigations and possible pharmacokinetic interaction of regorafenib.
Method: Regorafenib and sorafenib were eluted on Acquity UPLC®BEH C18 column. Elution was carried out by pumping mobile phase [methanol (0.1% formic acid): water (85:15%)] at 200µl/min flow rate. Mass detector was operated in multiple-reaction monitoring mode. Deprotonated ions [M-H]- of regorafenib and sorafenib were fragmented and monitored.
Results: Daughter fragments of regorafenib (m/z 481.1 > 194, m/z 481.1 > 260) and sorafenib (m/z 463 > 193.99, m/z 463 > 268.1) were determined in negative electrospray ionization mode. Linear calibration curve of range 50-2500 ng/ml was prepared in plasma. Method was selective, since there was no interfering peak at regorafenib retention time. Coefficients of variation for inter-day precision at three quality control concentrations were 17.6% at lower limit of quantitation, 6.3% at middle limit, and 2.9% at the highest limit of quantitation. Accuracy of the method ranged between 96% to 105.3%. Recovery of drug from blank plasma at quality control concentrations varied between 82.53 to 105.66%.
Conclusion: The developed method was successfully validated by adopting US FDA guidance for bioanalytical methods. The method is simple, quick and can be adopted for regorafenib estimation in other biological fluids with necessary modifications.
Keywords: Regorafenib, sorafenib, pharmacokinetics, bioanalysis, UPLC-MS/MS, elution.
Current Analytical Chemistry
Title:Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma
Volume: 14 Issue: 6
Author(s): Mohd Aftab Alam*, Fahad Ibrahim Al-Jenoobi, Ahmed Abdelrahman Abdelgalil and Abdullah Mohammed Al-Mohizea
Affiliation:
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh,Saudi Arabia
Keywords: Regorafenib, sorafenib, pharmacokinetics, bioanalysis, UPLC-MS/MS, elution.
Abstract: Background: Regorafenib is a multikinase inhibitor, indicated for the treatment of metastatic colorectal cancer and locally advanced, unresectable or metastatic gastrointestinal stromal tumor.
Objective: A simple and fast, validated bioanalytical method is required for pre-clinical or clinical safety and efficacy investigations and possible pharmacokinetic interaction of regorafenib.
Method: Regorafenib and sorafenib were eluted on Acquity UPLC®BEH C18 column. Elution was carried out by pumping mobile phase [methanol (0.1% formic acid): water (85:15%)] at 200µl/min flow rate. Mass detector was operated in multiple-reaction monitoring mode. Deprotonated ions [M-H]- of regorafenib and sorafenib were fragmented and monitored.
Results: Daughter fragments of regorafenib (m/z 481.1 > 194, m/z 481.1 > 260) and sorafenib (m/z 463 > 193.99, m/z 463 > 268.1) were determined in negative electrospray ionization mode. Linear calibration curve of range 50-2500 ng/ml was prepared in plasma. Method was selective, since there was no interfering peak at regorafenib retention time. Coefficients of variation for inter-day precision at three quality control concentrations were 17.6% at lower limit of quantitation, 6.3% at middle limit, and 2.9% at the highest limit of quantitation. Accuracy of the method ranged between 96% to 105.3%. Recovery of drug from blank plasma at quality control concentrations varied between 82.53 to 105.66%.
Conclusion: The developed method was successfully validated by adopting US FDA guidance for bioanalytical methods. The method is simple, quick and can be adopted for regorafenib estimation in other biological fluids with necessary modifications.
Export Options
About this article
Cite this article as:
Alam Aftab Mohd*, Al-Jenoobi Ibrahim Fahad, Abdelgalil Abdelrahman Ahmed and Al-Mohizea Mohammed Abdullah, Rapid UPLC Tandem Triple Quadrupole Mass Spectrometry Method for Determination of Regorafenib in Plasma, Current Analytical Chemistry 2018; 14 (6) . https://dx.doi.org/10.2174/1573411014666171204155553
DOI https://dx.doi.org/10.2174/1573411014666171204155553 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
Biogeochemistry: global environmental research and management
his issue focuses on the bio-pathways of trace elements (Ni, Co, Cr, Mn, Cd, Pb, Zn and REE) in soil, plant and atmospheric systems. Specific interest in the application of phytotechnologies that utilise hyperaccumulator plants (agro/phytomining). On the basis of understanding the migration and transformation of trace elements in ecosystem, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer
Current Cancer Drug Targets VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design The p53-Estrogen Receptor Loop in Cancer
Current Molecular Medicine The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer
Current Drug Targets Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry The Analysis of the Druggable Families Based on Topological Features in the Protein-Protein Interaction Network
Letters in Drug Design & Discovery Molecular Mechanism Behind the Synergistic Activity of Diphenylmethyl Selenocyanate and Cisplatin Against Murine Tumor Model
Anti-Cancer Agents in Medicinal Chemistry Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Current Cancer Drug Targets Advances in the Development of Anticancer HSP-based Vaccines
Current Medicinal Chemistry Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Anti-tumor Activity of Propofol: A Focus on MicroRNAs
Current Cancer Drug Targets Mitochondrial DNA Mutations in Cancer: A Review
Current Topics in Medicinal Chemistry Roles of UDP-Glucuronosyltransferases in Phytochemical Metabolism of Herbal Medicines and the Associated Herb-Drug Interactions
Current Drug Metabolism Antibody Directed Enzyme Prodrug Therapy (ADEPT) and Related Approaches for Anticancer Therapy
Mini-Reviews in Medicinal Chemistry The Prodrugs of 5-Fluorouracil
Current Medicinal Chemistry - Anti-Cancer Agents Structural and Functional Diversity of Estrogen Receptor Ligands
Current Topics in Medicinal Chemistry Array-Based Approaches for the Identification of Epigenetic Silenced Tumor Suppressor Genes
Current Genomics Wet-lab Tested MicroRNA Assays for qPCR Studies with SYBR<sup>®</sup> Green and DNA Primers in Pig Tissues
MicroRNA Aurora Kinase Inhibitors in Head and Neck Cancer
Current Topics in Medicinal Chemistry Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer
Current Drug Metabolism